PB Fintech Limited — Investor Meet, 01-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance:** PB Fintech reported a revenue growth of 48% year-on-year to ₹1,292 crore for Q3 FY 2024-25. The profit after tax (PAT) surged by 92% reaching ₹72 crore. Insurance premiums increased by 44% YoY to ₹6,135 crore, with the health insurance segment witnessing a significant 60% growth. However, their credit business saw a decline with disbursals dropping 20% year-on-year, reflecting a broader trend in the unsecured lending sector.

2. **Future Outlook and Growth Drivers:** Management expressed optimism for sustained growth, particularly in health and life insurance, attributing the slower savings growth to market conditions affecting ULIPs. Despite anticipated challenges in the savings segment, they are confident that core revenue growth will continue, driven primarily by enhancements and investments in operational capabilities.

3. **Order Book and Operational Updates:** The secured credit business, which is relatively new, is growing rapidly, with new disbursals reaching ₹2,570 crore in Q3. Management also reported a focus on expanding their agent aggregator platform, now serviced by 270,000 advisors, which is expected to bolster growth in the retail insurance segment.

4. **Analyst Q&A Insights (Detailed):**

- **Revenue and Profitability:** Analysts probed production margins and the impact of the underperformance in the savings segment. Management clarified that rapidly rising health business volumes continued to boost overall revenue but noted the expected profit pressure from underperforming savings initiatives.

- **Market Position and Competitive Landscape:** Questions focused on the firm’s competitive edge amid regulatory changes. Management highlighted their position in the market and belief in maintaining current growth without altering their strategic direction.

- **Operational Challenges or Risks:** Analysts brought up concerns regarding supply chain and lending issues. Management acknowledged the constraints in unsecured loans but indicated an anticipated recovery as market conditions normalize.

- **Capex and Capital Allocation:** Management discussed the need for strategic investment in growth areas while maintaining a careful watch on cost efficiencies amidst re-evaluation of operational needs.

- **Strategic Priorities and Long-Term Vision:** Long-term focus remains on substantial growth in health and life segments, with ongoing investments in technology and customer service improvements.

5. **Market or Regulatory Updates:** Discussions highlighted potential regulatory impacts on health insurance pricing and the firm’s strategic navigation through these challenges, emphasizing its intent to adapt while maintaining growth momentum.

6. **Strategic Focus Areas:** A clear emphasis on digital innovation, customer onboarding, and enhanced service delivery was noted, positioning the firm well against competitors and enhancing customer experience. Management's tone was positive regarding the company's adaptability and market strategies.

7. **Investor Insight:** The strong financial performance alongside strategic investments signals a robust growth trajectory, indicating potential for a 'buy' position. However, challenges in the savings segment warrant caution, suggesting a nuanced approach to future investments while monitoring market conditions.